Warwick SASCo Limited

Based in the UK, Warwick SASCo Limited specializes in the design and manufacture of high-quality medical polyware for the healthcare sector, ensuring efficient patient care through reliable sterilization solutions. Warwick SASCo Limited, founded in 1981, is based in Warwickshire, UK. The company focuses on producing medical polyware, catering to healthcare providers across the globe. It was formed with the goal of enhancing healthcare efficiency through its specialized products.

The company operates without any known parent or subsidiary companies and has successfully completed one major deal, with the most recent deal occurring on May 8, 2025, when it was acquired by Karnell. Financial terms of this transaction were not disclosed. Warwick SASCo Ltd specializes in the design and manufacture of high-quality medical polyware, primarily for the healthcare sector. Their product offerings include a wide range of sterilizable polyware such as compartment trays, instrument trays, and containers for disinfecting and soaking.

These products are vital for healthcare providers, including hospitals and veterinary clinics, enabling efficient patient care. The company serves over 65 countries and has upheld its ISO9001 certification since 1996, ensuring compliance with rigorous healthcare standards. Warwick SASCo Ltd primarily engages in B2B transactions, supplying its medical polyware directly to healthcare facilities and distributors. The revenue model focuses on bulk sales of key product lines, including the Warwick Range and Sterilite Range, through direct sales agreements and contracts with hospitals and clinics.

This structure fosters long-term partnerships and a robust revenue stream, driven by repeat business within the healthcare market. In May 2025, Warwick SASCo Limited was acquired by Karnell, a move aimed at accelerating growth. The company plans to expand its product line, although specific new products have not yet been disclosed. Furthermore, expansion into new geographic markets is anticipated, although targeted regions and timelines have not been specified.

The recent acquisition will support these initiatives, facilitating enhanced operational capabilities and market penetration.